Loading...
Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management
Ipilimumab plus nivolumab (Ipi/Nivo) has revolutionized advanced renal cell carcinoma (RCC) treatment. However, it encompassed fatal immune-related adverse events (irAEs). Myocarditis with concomitant myasthenia gravis (MG) has a mortality rate of 50%, and a high dose of methylprednisolone (mPSL) sh...
Na minha lista:
| Udgivet i: | Urol Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7726655/ https://ncbi.nlm.nih.gov/pubmed/33318935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2020.101508 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|